Last Updated 16 May 2022.
This vaccine is approved.
Approved in 111 countries
21 trials in 23 countries
Approval Source: africanews.com
Non Replicating Viral Vector
Approved in 140 countries
63 trials in 30 countries
Approval Source: unicef.org
© 2022 VIPER Group COVID19 Vaccine Tracker Team
Funding provided by the McGill University Interdisciplinary Initiative in Infection and Immunity (MI4)
This site is provided for informational purposes only based on publically available data.
Site Credits | Website Feedback Form